Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/13/20 → 7/29/21 |
Funding
- Chugai Pharmaceutical Company: $21,203.00
A Randomized, Double-Blind, Multiple Ascending Oral Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PCO371 in Patients with Hypoparathyroidism
- Ain, Kenneth (PI)